Skip to navigation Skip to main content Skip to footer

Approved Research

Periprostatic adipose tissue and aggressive prostate cancer risk: a prospective study

Principal Investigator: Dr Emma Allott
Approved Research ID: 97456
Approval date: June 20th 2023

Lay summary

Obesity is associated with increased risk of aggressive prostate cancer, but the exact mechanisms contributing to this relationship are not completely understood. Excess fat surrounding internal organs is now understood to be harmful to health, and the prostate is no exception in being enveloped by a layer of fat. This so-called periprostatic fat is difficult to measure due to its location within the pelvis and can only be assessed using imaging techniques. As such, how the amount of periprostatic fat varies between individuals has never before been assessed in a healthy population, and its relationship with prostate cancer risk is unknown. We hypothesize that an increased amount of fat around the prostate may result in an increased risk of aggressive prostate cancer.

The aim of this project is to examine the amount of fat surrounding the prostate as a risk factor for aggressive prostate cancer. This project will analyse whole body imaging scans uniquely available in large groups of healthy men participating in UK Biobank to measure the quantity and assess the characteristics of periprostatic fat. We will also identify small alterations in the genetic code of these individuals that predict an increased amount of periprostatic fat. Hundreds of aggressive cases of prostate cancer have been newly diagnosed in these men, and we will test, for the first time, whether an increased amount of fat surrounding the prostate could affect a man's future risk of being diagnosed with a more aggressive prostate cancer.

The following objectives will be carried out over a 3-year period:

1) To measure periprostatic fat in healthy men and to describe the characteristics of men with increased amounts of this fat type

2) To identify genetic predictors of increased periprostatic fat, and use a so-called Mendelian Randomization analysis to determine their relationship with aggressive prostate cancer

3) To examine whether men with higher amounts of periprostatic fat are at increased risk of aggressive prostate cancer

The public health impact of this work is that identifying lifestyle characteristics of men with higher amounts of periprostatic fat could suggest possible lifestyle modifications to reduce the size of this fat depot to potentially lower their risk of developing an aggressive prostate tumour. More insight into the relationship between periprostatic fat and aggressive prostate cancer could lead to intervention studies and, ultimately, will inform future policies to prevent aggressive prostate cancer.